The clinical antidepressant effect of exogenous agmatine is not reversed by parachlorophenylalanine: a pilot study
Notes for this study:
| Effect | Decrease |
| Trial Design | cohort |
| Trial Length | 16months |
| Number of Subjects | 3 |
| Sex | mixed |
Oral ingestion of 2-3 g agmatine over 6-8 weeks in three subjects who were diagnosed with either major depressive disorder or unipolar depression, who were not on any pharmaceuticals nor did they have treatment-resistant depression, was able to induce remission of depressive symptoms in all subjects.
